- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/452 - Piperidinium derivatives
Patent holdings for IPC class A61K 31/452
Total number of patents in this class: 131
10-year publication summary
|
5
|
9
|
5
|
14
|
17
|
15
|
11
|
5
|
2
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nocion Therapeutics, Inc. | 50 |
12 |
| Satiogen Pharmaceuticals, Inc. | 12 |
5 |
| Fosun Orinove Pharmatech, Inc. | 12 |
5 |
| Takeda Pharmaceutical Company Limited | 2717 |
4 |
| Amicus Therapeutics, Inc. | 354 |
4 |
| University of Florida Research Foundation, Inc. | 4156 |
3 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2262 |
3 |
| LTT Bio-Pharma Co., Ltd. | 44 |
3 |
| West China Hospital, Sichuan University | 233 |
3 |
| Lophora ApS | 8 |
3 |
| Libertas bio, Inc. | 23 |
3 |
| The General Hospital Corporation | 4844 |
2 |
| Asana Biosciences, LLC | 43 |
2 |
| Barry University, Inc. | 4 |
2 |
| Case Western Reserve University | 1877 |
2 |
| Children's Medical Center Corporation | 1939 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2648 |
2 |
| Khondrion IP B.V. | 21 |
2 |
| Korea Research Institute of Chemical Technology | 1453 |
2 |
| PnP Biopharm Co., Ltd. | 18 |
2 |
| Other owners | 65 |